Cyclophosphamide

CHEMBL1200796 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
261.1 g/mol
LogP
0.6
Phase
4

A nitrogen mustard alkylating agent that cross-links DNA strands to kill rapidly dividing cells, used to treat various cancers including lymphoma, leukemia, and breast cancer, as well as severe autoimmune diseases. It requires activation by liver enzymes and can cause serious side effects including hemorrhagic cystitis.

Peso Molecular

261,0800 g/mol

LogP

0,60

TPSA

41,60 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Mecanismo de Ação

Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O.O=P1(N(CCCl)CCCl)NCCCO1

InChI

InChI=1S/C7H15Cl2N2O2P.H2O/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14;/h1-7H2,(H,10,12);1H2

Molecular Formula

C7H15Cl2N2O2P

HBD / HBA

1 / 4

Ligações Rotacionáveis

5

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A nitrogen mustard alkylating agent that cross-links DNA strands to kill rapidly dividing cells, used to treat various cancers including lymphoma, leukemia, and breast cancer, as well as severe autoimmune diseases. It requires activation by liver enzymes and can cause serious side effects including hemorrhagic cystitis.

Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.

Yes, Cyclophosphamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200796. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2907. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.